Skip to main content
PLOS One logoLink to PLOS One
. 2021 Aug 25;16(8):e0256415. doi: 10.1371/journal.pone.0256415

Towards stronger antenatal care: Understanding predictors of late presentation to antenatal services and implications for obstetric risk management in Rwanda

Christina N Schmidt 1,*, Elizabeth Butrick 2, Sabine Musange 3, Nathalie Mulindahabi 3, Dilys Walker 2,4
Editor: Adeniyi Francis Fagbamigbe5
PMCID: PMC8386859  PMID: 34432829

Abstract

Background

Early antenatal care (ANC) reduces maternal and neonatal morbidity and mortality through identification of pregnancy-related complications, yet 44% of Rwandan women present to ANC after 16 weeks gestational age (GA). The objective of this study was to identify factors associated with delayed initiation of ANC and describe differences in the obstetric risks identified at the first ANC visit (ANC-1) between women presenting early and late to care.

Methods

This secondary data analysis included 10,231 women presenting for ANC-1 across 18 health centers in Rwanda (May 2017-December 2018). Multivariable logistic regression models were constructed using backwards elimination to identify predictors of presentation to ANC at ≥16 and ≥24 weeks GA. Logistic regression was used to examine differences in obstetric risk factors identified at ANC-1 between women presenting before and after 16- and 24-weeks GA.

Results

Sixty-one percent of women presented to ANC at ≥16 weeks and 24.7% at ≥24 weeks GA, with a mean (SD) GA at presentation of 18.9 (6.9) weeks. Younger age (16 weeks: OR = 1.36, 95% CI: 1.06, 1.75; 24 weeks: OR = 1.33, 95% CI: 0.95, 1.85), higher parity (16 weeks: 1–4 births, OR = 1.55, 95% CI: 1.39, 1.72; five or more births, OR = 2.57, 95% CI: 2.17, 3.04; 24 weeks: 1–4 births, OR = 1.93, 95% CI: 1.78, 2.09; five or more births, OR = 3.20, 95% CI: 2.66, 3.85), lower educational attainment (16 weeks: primary, OR = 0.75, 95% CI: 0.65, 0.86; secondary, OR = 0.60, 95% CI: 0.47,0.76; university, OR = 0.48, 95% CI: 0.33, 0.70; 24 weeks: primary, OR = 0.64, 95% CI: 0.53, 0.77; secondary, OR = 0.43, 95% CI: 0.29, 0.63; university, OR = 0.12, 95% CI: 0.04, 0.32) and contributing to household income (16 weeks: OR = 1.78, 95% CI: 1.40, 2.25; 24 weeks: OR = 1.91, 95% CI: 1.42, 2.55) were associated with delayed ANC-1 (≥16 and ≥24 weeks GA). History of a spontaneous abortion (16 weeks: OR = 0.74, 95% CI: 0.66, 0.84; 24 weeks: OR = 0.70, 95% CI: 0.58, 0.84), pregnancy testing (16 weeks: OR = 0.48, 95% CI: 0.33, 0.71; 24 weeks: OR = 0.41, 95% CI: 0.27, 0.61; 24 weeks) and residing in the same district (16 weeks: OR = 1.55, 95% CI: 1.08, 2.22; 24 weeks: OR = 1.73, 95% CI: 1.04, 2.87) or catchment area (16 weeks: OR = 1.53, 95% CI: 1.05, 2.23; 24 weeks: OR = 1.84, 95% CI: 1.28, 2.66; 24 weeks) as the health facility were protective against delayed ANC-1. Women with a prior preterm (OR, 0.71, 95% CI, 0.53, 0.95) or low birthweight delivery (OR, 0.72, 95% CI, 0.55, 0.95) were less likely to initiate ANC after 16 weeks. Women with no obstetric history were more likely to present after 16 weeks GA (OR, 1.18, 95% CI, 1.06, 1.32).

Conclusion

This study identified multiple predictors of delayed ANC-1. Focusing existing Community Health Worker outreach efforts on the populations at greatest risk of delaying care and expanding access to home pregnancy testing may improve early care attendance. While women presenting late to care were less likely to present without an identified obstetric risk factor, lower than expected rates were identified in the study population overall. Health centers may benefit from provider training and standardized screening protocols to improve identification of obstetric risk factors at ANC-1.

Introduction

Attendance at antenatal care (ANC) is important for the health outcomes of expectant mothers and future neonates. Through early identification, management and referral of pregnancy-related complications, ANC can contribute to reductions in maternal and neonatal morbidity and mortality [15]. While global maternal and neonatal mortality rates fell by 44% [6] and 47% [7] between 1990 and 2015, inequities persist across geographic regions. Sub-Saharan Africa maintains the highest regional rate of maternal mortality, accounting for more than half of maternal deaths globally [6]. The region also has the highest neonatal mortality rate, comprising 41% of neonatal deaths worldwide [8].

Many obstetric complications leading to adverse outcomes for mothers and neonates can be effectively managed if identified at an ANC visit early in pregnancy. Leading causes of maternal mortality in sub-Saharan Africa, including hypertensive disorders and pregnancy-related infections, can be mitigated in the antenatal period resulting in lower mortality rates [9, 10]. Decreased rates of preterm birth, a common cause of neonatal morbidity and mortality in low-resources settings, have been linked to increased attendance at ANC [11]. Surveillance throughout the antenatal period for conditions such as diabetes, anemia and HIV can further reduce obstetric complications through early monitoring and management [12, 13]. Attendance at ANC may also increase the usage of emergency obstetric care [14], and motivate women to deliver at a health facility [15]. Given the known benefits to mothers and neonates, Rwanda has made increasing attendance at ANC a national priority [16].

Despite recognition of the importance of early ANC attendance, many pregnant women in resource-poor settings continue to present late to care. In Rwanda, women are encouraged to present to ANC before 16 weeks GA and attend four prenatal visits, yet compliance with ANC schedules is low. The 2015 Rwandan Demographic and Health Survey found that only 56% of women present to ANC before 16 weeks GA [16]. This is consistent with literature from the sub-Saharan Africa region, which has frequently reported high rates of late presentation to ANC [1618]. While 99% of pregnant women in Rwanda attend at least one ANC visit prior to delivery, only 52% attend 2 or 3 visits and only 44% attend the Rwandan Ministry of Health’s recommended four ANC visits [16].

Various predictors of delayed initiation of ANC have been identified in low-resource countries. These include lower educational attainment, decreased household income, higher cost of care and unemployment [19]. In sub-Saharan Africa, unplanned pregnancy, increased distance from a health facility and food insecurity have also been associated with late presentation to ANC [4, 16, 1923]. The financial burden of seeking care, completing demands on family resources, and long travel times may make accessing care a challenge for families. In Rwanda, cultural norms, such as the practice of disclosing pregnancy after the second trimester, when the pregnancy is externally visible, have been suggested as a reason for delayed ANC initiation [24]. Negative experiences with ANC providers, including receiving criticism for registering for care either too early or too late, or arriving without accompaniment by a male partner, have also been reported as barriers to attending ANC in Rwanda [24].

Some evidence also suggests that women present late to ANC because they believe that their pregnancies are low-risk [2426]. This may be especially true among multiparous women with a history of uncomplicated births [21, 26, 27]. Various studies have shown that increased parity and a history of uncomplicated deliveries are associated with delayed ANC [19, 20], which may be due to reassurance from previous uncomplicated pregnancies. Women with uncomplicated prior pregnancies may actually be at lower risk of developing certain obstetric complications compared to their nulliparous counterparts. The strongest predictor of complications such as preterm birth and pre-eclampsia, for example, is a history of these conditions in a prior pregnancy [2729].

Improving ANC attendance has become increasingly relevant in the wake of the World Health Organization’s 2016 release of clinical guidelines recommending that women have at least eight contacts with the health system throughout their pregnancies [12]. Previously, the World Health Organization’s focused antenatal care (FANC) strategy encouraged four ANC visits during the prenatal period [30, 31]. While the World Health Organization asserts that increasing the number of ANC contacts leads to improved health outcomes, some data suggest that the quality and content of ANC care, rather than the number of contacts, has a greater impact on maternal and neonatal outcomes [3133]. Results from one systematic review suggest that women with low-risk pregnancies can safely have fewer ANC visits [34]. As international recommendations shift towards increasing the number of ANC contacts, understanding predictors of late presentation to care, as well as the impact of late presentation on clinically significant outcomes is increasingly relevant.

This analysis identified predictors of late (≥16 weeks GA) and very late (≥24 weeks GA) presentation to ANC among a cohort of 10,231 women enrolled in a randomized controlled trial on prenatal care and birth outcomes in Rwanda (The Preterm Birth Initiative–Rwanda) [35]. Through understanding predictors of delayed presentation to care, and identifying which factors are most amenable to change, policymakers can more effectively develop strategies to increase earlier attendance at ANC visits. This analysis also assessed differences in the pregnancy-related risk factors identified at a woman’s first ANC visit, based on both parity and GA at presentation to care. Understanding the differences in risk profiles between pregnant women who present early and those who present late to ANC will contribute to how we understand the risks of late presentation and inform messages tailored to multiparous and nulliparous women.

Methods

Study design and population

This secondary data analysis used data obtained in a cluster randomized controlled trial on prenatal care and birth outcomes, conducted by The Preterm Birth Initiative–Rwanda (NCT03154177) [35]. The present analysis was restricted to health centers randomized to the control group, which included 18 facilities in 5 districts (Bugesera, Rubavu, Nyamasheke, Nyarugenge, and Burera). These health centers were selected for inclusion in the trial based on their location in one of the five districts, their monthly ANC volume, and the presence of at least two ANC providers at the facility. Women ≥15 years of age who presented to one of the participating health centers between May 2017 and December 2018 for ANC services were invited to enroll in the study. Only participants with completed ANC records were included in the final analysis. There were no significant differences in the characteristics of those with incomplete ANC records, as determined by linear models of key sociodemographic variables.

Enrollment surveys

Trained data collectors employed by the research team were embedded at each of the 18 health centers. After introducing the study to each woman presenting for ANC, data collectors obtained consent for participants to be included in the study. Upon enrollment, data collectors administered an initial survey to all participants (S1 File). Data collected included age, educational attainment, occupation, contribution to household income, level of partner communication, proximity of the health center to their home and tobacco and alcohol use. Food security over the past month was assessed with a two-question series recommended by the American Association of Pediatrics [36]. Women were also asked whether they had received a pregnancy test and/or whether a community health worker (CHW) had recommended that they visit a health center to confirm their pregnancy.

Multiparous participants were asked to report any previous preterm births, low birth weight infants, fresh stillbirths, neonatal deaths (first 28 days of life) and repeated miscarriages. These participants were also asked to report the number of ANC appointments that they attended during their most recent past pregnancy.

Antenatal visit data

Data from participants’ first ANC visit (ANC-1) were abstracted from existing national collection tools, including health center registers and patient files. All health centers participated in data strengthening training prior to the start of the study to improve accuracy and completeness of these existing data collection tools. Information abstracted from participants’ antenatal registers included gravidity, parity, and GA at ANC-1. Obstetric risk factors included the presence of anemia, proteinuria, hypertension (≥140/90), multiple births, middle upper arm circumference (MUAC) <21cm, and HIV positive status (either positive test or known positive status documented in the chart). Syphilis or malaria identified at ANC-1 were also recorded. If no obstetric risk factors were identified in the chart, data collectors recorded “none.” Additional history collected from participants’ ANC-1 files included a documented history of diabetes and/or chronic hypertension. In Rwanda, anemia, proteinuria, hypertension, multiple births, MUAC <21cm, diabetes, and syphilis are universally screened for at ANC-1 and noted as either present or absent in the maternity register using tick boxes.

Analysis

The primary outcomes in this analysis were late and very late presentation to ANC. Late presentation was defined as ≥16 weeks GA in accordance with the Rwandan Ministry of Health’s prenatal care performance indicators, and very late was defined as ≥24 weeks GA [37]. Univariate logistic regression models were constructed to identify variables significantly associated with late presentation to ANC at both GA cut-offs for all 10,231 participants, both nulliparous and multiparous. Variables assessed included age, educational attainment, employment, contribution to household income, food insecurity, health center proximity, prior spontaneous abortion, gravidity/parity, pregnancy testing, CHW recommended health center visit, partner communication and the health center proximity.

Variables that were significantly associated with delayed presentation to ANC at the αcrit = 0.20 level in univariate analyses were retained for multivariable model building [38, 39]. For covariates that were identified to be collinear (variance inflation factor >2.5) the variable more strongly associated with delayed ANC was retained. Final multivariable logistic regression models were constructed using manual backwards elimination. A full model including all candidate predictors was constructed, and the predictor with the highest p-value greater than αcrit = 0.20 was removed. The model was refit and this process was repeated until all variables maintained in the model had a p-value less than αcrit, with the exception of age which was considered by the investigators to be a potential confounder. Cluster-robust standard errors were used to account for the clustering effects of health centers. Odds ratios and 95% confidence intervals are reported.

For the 7,380 multiparous participants, obstetrics history predictors of late (≥16 weeks GA) and very late (≥24 weeks GA) presentation to ANC were assessed using logistic regression models. Obstetric history variables included a history of a preterm delivery, low birthweight infant, previous fresh stillbirth, 28-day mortality of a neonate, and repeated miscarriages. Self-reported ANC attendance in the most recent prior pregnancy was also assessed.

The secondary outcomes of interest were the obstetric risk factors identified at ANC-1. Logistic regression models were used to identify associations between late and very late presentation to ANC and the types of obstetric risk factors identified at a woman’s first ANC visit. Risk factors assessed included anemia, proteinuria, hypertension, multiple births, smoking, alcohol use, HIV positive status, and MUAC <21. Diabetes, syphilis and malaria were not reliably recorded in the ANC-1 records, and thus were excluded from the final analysis.

Additional logistic regression models were also used to assess for associations between parity and the identification of pregnancy-related risk factors at ANC-1. To assess whether parity was a moderator of the relationship between GA at ANC-1 and each of the obstetric risk factors identified at ANC-1, logistic regression models with interaction terms were used. All analyses were conducted in R (version 3.6.1).

Ethical considerations

This study was approved by the Rwanda National Ethics Committee (No.0034/RNEC/2017), and the University of California, San Francisco Institutional Review Board (16–21177). Written consent was obtained from all participants prior to administering the enrollment survey and reviewing patient health records. All consent forms were translated into Kinyarwanda. Participants provided consent by reading and signing the consent form. For participants who were illiterate, a member of the study team verbally read the consent form in the presence of a witness and both the consented participant and witness signed the consent. The Rwandan National Ethics Committee and the University of California, San Francisco Institutional Review Board waived parental consent requirements for pregnant minors.

Results

Predictors of delayed ANC

Data were analyzed for 10,231 eligible women presenting to ANC-1 at participating health centers. The majority of women (72.3%) were between the ages of 20–35 (mean 28.9 years) and most (53.9%) had not completed primary school. Sixty one percent of women presented to ANC at ≥16 weeks GA, and 25% presented to ANC at ≥24 weeks GA, with an mean (SD) GA at presentation of 18.9 (6.9) weeks. Seventy two percent of the women in the cohort were multiparous, and of these multiparous women 37.5% had attended ≥4 ANC visits during their most recent prior pregnancy.

Several factors were significantly associated with late and very late presentation to ANC in univariate models (Table 1). Age (p<0.001), lower educational attainment (p<0.001), contribution to household income (p<0.001), gravity (p<0.001), parity (p<0.001), and recommendation from a CHW to visit a health center to confirm pregnancy (p<0.001) were significantly associated with presentation to ANC at ≥16 weeks and ≥24 weeks GA. History of a spontaneous abortion (16 weeks, p<0.003; 24 weeks, p = 0.005), and pregnancy testing (p<0.001) were protective against late presentation to ANC. Food insecurity was associated with presentation to ANC at ≥24 weeks GA (p<0.001), and decreased communication between partners was associated with presentation at ANC ≥16 weeks GA (p = 0.001). There were significant differences in the rate of late presentation (≥16 and ≥ 24 weeks GA) between districts (p<0.001).

Table 1. Univariate relationships between sociodemographic factors and delayed antenatal care.

Characteristic ≥ 16 weeks gestational age ≥ 24 weeks gestational age
N % OR 95% CI P-value N % OR 95% CI P-value
Age (ref = 25–29 years) <0.001 <0.001
 15–19 477 6.2 1.04 0.87, 1.25 119 4.7 0.83 0.67, 1.03
  20–24 1862 24.2 0.95 0.85, 1.06 514 20.3 0.92 0.81, 1.05
  25–29 2091 27.1 1.00 (ref) 626 24.8 1.00 (ref)
  30–34 1698 22.0 1.19 1.06, 1.33 609 24.1 1.20 1.05, 1.36
  35+ 1577 20.5 1.29 1.15, 1.45 658 26.0 1.39 1.23, 1.58
Gravidity (ref = 1) <0.001 <0.001
  1 1430 22.9 1.00 (ref) 441 17.5 1.00 (ref)
  2–4 3130 50.1 1.38 1.25, 1.51 1275 50.5 1.68 1.49, 1.90
  5+ 1686 27.0 1.88 1.67, 2.10 810 32.1 2.47 2.16, 2. 82
Parity (ref = 0) <0.001 <0.001
  0 1522 24.4 1.00 (ref) 459 18.2 1.00 (ref)
  1–4 3809 61.0 1.45 1.32, 1.59 1609 63.7 1.87 1.67, 2.01
  5+ 915 14.6 2.18 1.89, 2.52 458 18.1 2.90 2.49, 3.38
Educational attainment (ref = none) <0.001 <0.001
  None 3578 57.3 1.00 (ref) 1621 64.2 1.00 (ref)
  Primary 2168 34.7 0.74 0.68, 0.81 773 30.6 0.62 0.56, 0,69
  Secondary 450 7.2 0.62 0.53, 0.72 127 5.0 0.43 0.35, 0.52
  University 50 0.8 0.52 0.35, 0.77 5 0.2 0.12 0.04, 0.28
Employed (ref = no) 5678 90.9 0.93 0.81, 1.07 0.309 2321 91.9 1.13 0.97, 1.34 0.127
Contributes to household income (ref = no) 1499 24.0 1.53 1.38, 1.69 <0.001 700 27.7 1.61 1.45, 1.79 <0.001
Food insecurity (ref = no) 3942 63.1 0.93 0.86, 1.02 0.115 1687 66.8 1.20 1.09, 1.31 <0.001
Prior spontaneous abortion (ref = no) 651 10.4 0.83 0.73, 0.94 0.003 243 9.6 0.81 0.69, 0.93 0.005
Pregnancy test (ref = no) 357 5.7 0.49 0.42, 0.56 <0.001 102 4.0 0.42 0.34, 0.52 <0.001
CHW recommended health center visit (ref = no) 1830 29.3 0.86 0.79, 0.94 <0.001 690 27.3 0.81 0.74, 0.90 <0.001
Open communication with partner (ref = no) 5643 90.3 0.79 0.69, 0.91 0.001 2299 91.0 0.99 0.85, 1.16 0.914
Health center proximity (ref = resides outside of district) 0.486 <0.001
  Resides outside of district 54 0.9 1.00 (ref) 16 0.6 1.00 (ref)
  Resides within district 848 13.6 1.37 0.92, 2.02 330 13.1 1.76 1.06, 3.13
  Resides within catchment area 5344 85.6 1.38 0.90, 2.07 2180 86.3 1.67 0.99, 2.98
District (ref = Rubavu) <0.001 0.035
  Bugesera 1645 26.3 0.30 0.27, 0.34 481 19.0 0.19 0.17, 0.21
  Burera 1110 17.8 0.25 0.21, 0.28 347 13.7 0.18 0.16, 0.21
  Nyarugenge 769 12.3 0.18 0.15, 0.20 234 9.3 0.15 0.12, 0.17
  Nyamasheke 793 12.7 0.35 0.30, 0.41 241 9.5 0.21 0.18, 0.25
  Rubavu 2698 43.2 1.00 (ref) 1457 57.7 1.00 (ref)

The association between having a history of an obstetric complication and GA at ANC-1 among multiparous women is reported in Table 2. Women with no obstetric history were more likely to present at ≥16 weeks GA (OR, 1.18, 95% CI, 1.06, 1.32), while women with a history of a preterm delivery (OR, 0.71, 95% CI, 0.53, 0.95) and low birthweight baby (OR, 0.72, 95% CI, 0.55, 0.95) were less likely to delay care beyond 16 weeks GA. Other obstetric risk factors (fresh stillbirth, 28-day neonatal mortality and repeated miscarriage) were not associated with timing of ANC-1. Attending ≥4 ANC visit in the most recent prior pregnancy was associated with a decreased risk of delayed ANC-1 (16 weeks: OR, 0.66, 95% CI, 0.62, 0.70; 24 weeks: OR, 0.61, 95% CI, 0.57, 0.65).

Table 2. Univariate relationships between obstetric history and delayed antenatal care.

Obstetric history ≥ 16 weeks gestational age ≥ 24 weeks gestational age
N % OR 95% CI P-value N % OR 95% CI P-value
None 3688 78.1 1.18 1.06, 1.32 0.003 1614 78.1 1.09 0.97, 1.23 0.164
Preterm delivery 107 2.3 0.71 0.53, 0.95 0.020 42 2.0 0.72 0.50, 1.01 0.062
Low birthweight infant 125 2.6 0.72 0.55, 0.95 0.020 59 2.9 0.93 0.69, 1.26 0.659
Previous fresh stillbirth 220 4.7 0.96 0.77, 1.20 0.698 95 4.6 0.96 0.75, 1.22 0.737
28-day mortality of a neonate 118 2.5 1.04 0.77, 1.42 0.815 54 2.6 1.09 0.78, 1.49 0.613
Repeated miscarriage 118 2.5 0.86 0.64, 1.15 0.303 48 2.3 0.84 0.60, 1.15 0.286
≥4 ANC visits in last pregnancy 1511 32.0 0.66 0.62, 0.70 <0.001 511 24 0.61 0.57, 0.65 <0.001

Both full and reduced multivariable models for late (≥16 weeks GA) and very late (≥24 weeks GA) presentation to ANC are shown in Table 3. Factors significantly associated with late presentation to ANC included increased parity (1–4 births, OR = 1.55, 95% CI: 1.39, 1.72; five or more births, OR = 2.57, 95% CI: 2.17, 3.04), lower educational attainment (primary, OR = 0.75, 95% CI: 0.65, 0.86; secondary, OR = 0.60, 95% CI: 0.47,0.76; university, OR = 0.48, 95% CI: 0.33, 0.70), contributing to household income (OR = 1.78, 95% CI: 1.40, 2.25) and residing in the same district (OR = 1.55, 95% CI: 1.08, 2.22) or catchment area (OR = 1.53, 95% CI: 1.05, 2.23) as the health facility. These same factors–increased parity (1–4 births, OR = 1.93, 95% CI: 1.78, 2.09; five or more births, OR = 3.20, 95% CI: 2.66, 3.85), lower educational attainment (primary, OR = 0.64, 95% CI: 0.53, 0.77; secondary, OR = 0.43, 95% CI: 0.29, 0.63; university, OR = 0.12, 95% CI: 0.04, 0.32), contributing to household income (OR = 1.91, 95% CI: 1.42, 2.55) and residing in the same district (OR = 1.73, 95% CI: 1.04, 2.87) or catchment area (OR = 1.84, 95% CI: 1.28, 2.26) as the health facility–were also associated with very late presentation to care. History of a spontaneous abortion (16 weeks: OR = 0.74, 95% CI: 0.66, 0.84; 24 weeks: OR = 0.70, 95% CI: 0.58, 0.84) and receiving a pregnancy test (16 weeks: OR = 0.48, 95% CI: 0.33, 0.71; 24 weeks: OR = 0.41, 95% CI: 0.27, 0.61) were protective against late and very late presentation to ANC. Younger age (15–19 years) predicted presentation to ANC at ≥16 weeks GA (OR = 1.36, 95% CI: 1.06, 1.75) and at ≥24 weeks GA (OR = 1.33, 95% CI: 0.95, 1.85), although the latter was not statistically significant. Employment predicted presentation to care at ≥16 weeks GA (OR = 0.64, 95% CI: 0.51, 0.82) and at ≥24 weeks GA (OR = 0.69, 95% CI: 0.46, 1.04), although again the latter was not statistically significant.

Table 3. Multivariable predictors of late and very late presentation to antenatal care.

Characteristic ≥ 16 weeks gestational age ≥ 24 weeks gestational age
Full Reduced Full Reduced
OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value
Age (ref = 25–29 years)
  15–19 1.36 1.06,1.73 0.014 1.36 1.06,1.75 0.016 1.33 0.97,1.83 0.080 1.33 0.95,1.85 0.094
  20–24 1.13 0.95,1.35 0.178 1.13 0.95,1.35 0.160 1.21 1.03,1.42 0.020 1.20 1.03,1.41 0.020
  25–29 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
  30–34 1.04 0.92,1.19 0.505 1.04 0.92,1.19 0.506 0.99 0.85,1.17 0.950 0.99 0.85,1.17 0.943
  35+ 0.94 0.82,1.08 0.376 0.94 0.82,1.07 0.365 0.94 0.82,1.08 0.389 0.94 0.82,1.08 0.368
Parity (ref = 0)
  0 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
  1–4 1.56 1.39,1.74 <0.001 1.55 1.39,1.72 <0.001 1.91 1.74,2.10 <0.001 1.93 1.78,2.09 <0.001
  5+ 2.60 2.20,3.08 <0.001 2.57 2.17,3.04 <0.001 3.15 1.82,5.74 <0.001 3.20 2.66,3.85 <0.001
Educational attainment (re = none)
  None 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
  Primary 0.74 0.64,0.85 <0.001 0.75 0.65,0.86 <0.001 0.65 0.54,0.77 <0.001 0.64 0.53,0.77 <0.001
  Secondary 0.58 0.46,0.75 <0.001 0.60 0.47,0.76 <0.001 0.44 0.30,0.63 <0.001 0.43 0.29,0.63 <0.001
  University 0.46 0.31,0.69 <0.001 0.48 0.33,0.70 <0.001 0.12 0.04,0.35 <0.001 0.12 0.04,0.32 <0.001
Employed (ref = no)
  No 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
  Yes 0.65 0.51,0.84 <0.001 0.64 0.51,0.82 <0.001 0.68 0.47,0.99 0.046 0.69 0.46,1.04 0.077
Contributes to household income (ref = no)
  No 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
  Yes 1.74 1.38,2.20 <0.001 1.78 1.40,2.25 <0.001 1.95 1.47,2.58 <0.001 1.91 1.42,2.55 <0.001
Prior spontaneous abortion (ref = no)
  No 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
  Yes 0.74 0.66,0.84 <0.001 0.74 0.66,0.84 <0.001 0.70 0.58,0.84 <0.001 0.70 0.58,0.84 <0.001
Pregnancy test (ref = no)
  No 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
  Yes 0.47 0.32,0.69 <0.001 0.48 0.33,0.71 <0.001 0.42 0.29,0.61 <0.001 0.41 0.27,0.61 <0.001
Health center proximity (ref = resides out of district)
  Resides outside of district 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
  Resides within district 1.56 1.08,2.25 0.024 1.55 1.08,2.22 0.017 1.72 1.04,2.83 0.034 1.73 1.04,2.87 0.034
  Resides within catchment area 1.55 1.06,2.26 0.017 1.53 1.05,2.23 0.026 1.82 1.28,2.58 <0.001 1.84 1.28,2.66 <0.001
CHW recommended health center visit (ref = no)
  No 1.00 (ref) 1.00 (ref)
  Yes 1.03 0.82,1.30 0.793 0.97 0.74,1.27 0.826
Food insecurity (ref = no)
  No 1.00 (ref) 1.00 (ref)
  Yes 0.90 0.71,1.13 0.356 1.12 0.82,1.54 0.457
Open communication with partner (ref = no)
  No 1.00 (ref) 1.00 (ref)
  Yes 0.72 0.56,0.93 0.011 0.72 0.56,0.93 0.011

Obstetric risk factors identified at ANC-1

Analyses of obstetric risk factors identified at ANC-1 revealed differences in documented risk factors based on both GA at presentation to care and parity (Table 4). Women presenting to care at ≥16 and ≥24 weeks GA were more likely to have multiple births (16 weeks: OR = 1.90, 95% CI: 1.47, 2.50; 24 weeks: OR = 1.74, 95% CI: 1.36, 2.21) and a history of alcohol use (16 weeks: OR = 1.16, 95% CI: 1.04, 1.29; 24 weeks: OR = 1.15, 95% CI: 1.01, 1.29). Patients who presented at <16 and <24 weeks GA were more likely to have proteinuria at ANC-1 (16 weeks: OR = 0.62, 95% CI: 0.56, 0.68; 24 weeks: OR = 0.62, 95% CI: 0.55, 0.72). Overall, women presenting to care at <16 weeks GA were more likely to have no obstetric risk factors identified and documented at ANC-1 (OR = 0.74, 95% CI: 0.63, 0.86) (Table 4).

Table 4. Obstetric risk factors identified at ANC-1 associated with delayed antenatal care in univariate models.

Characteristics ≥ 16 weeks gestational age ≥ 24 weeks gestational age
N % OR 95% CI P-value N % OR 95% CI P-value
None 5740 91.9 0.74 0.63, 0.86 <0.001 2320 91.8 0.85 0.72, 1.01 0.064
Anemia 154 2.5 0.99 0.77, 1.28 0.953 52 2.1 0.78 0.57, 1.06 0.123
Proteinuria 981 15.7 0.62 0.56, 0.68 <0.001 345 13.7 0.62 0.55, 0.71 <0.001
Hypertension 16 0.3 5.11 1.45, 32.4 0.030 5 0.2 1.17 0.38, 3.11 0.761
HIV 135 2.2 0.73 0.53, 1.00 0.049 32 1.3 0.77 0.51, 1.12 0.180
MUAC <21cm 135 2.2 1.14 0.86, 1.52 0.378 51 2.0 0.97 0.70, 1.33 0.860
Smoking 42 0.7 0.76 0.49, 1.20 0.241 12 0.5 0.56 0.29, 1.00 0.067
Alcohol use 1006 16.1 1.16 1.04, 1.29 0.010 423 16.7 1.15 1.01, 1.29 0.028
Multiple births 220 3.5 1.90 1.47, 2.50 <0.001 106 4.2 1.74 1.36, 2.21 <0.001

Differences in obstetric risk factors identified at first ANC visit based on parity are reported in Table 5. Multiparous women (n = 7380) were more likely to have multiple births (OR = 58.9, 95% CI: 18.9, 335) and report alcohol use (OR = 1.68, 95% CI: 1.48, 1.93) at their first ANC visit. Women who were nulliparous were more likely to have no obstetric risk factors documented at ANC-1 (OR = 0.28, 95% CI: 0.22, 0.35). Parity was not a moderator of the relationship between GA at presentation to care and any of the obstetric risk factors identified at ANC-1 in our moderator analyses.

Table 5. Obstetric risk factors identified at ANC-1 associated with parity in univariate models.

Characteristics Nulliparous Multiparous
N % N % OR 95% CI P-value
None 2774 97.3 6708 90.9 0.28 0.22, 0.35 <0.001
Anemia 82 2.9 171 2.3 0.80 0.62, 1.05 0.376
Proteinuria 503 17.6 1400 19.0 1.09 0.98, 1.22 0.734
Hypertension 3 0.1 15 0.2 1.93 0.64, 8.35 0.297
HIV 33 1.2 126 1.7 1.48 1.02, 2.22 0.045
MUAC <21cm 57 2.0 154 2.1 1.04 0.77, 1.43 0.780
Smoking 19 0.7 58 0.8 1.18 0.72, 2.04 0.531
Alcohol use 311 10.9 1262 17.1 1.68 1.48, 1.93 <0.001
Multiple births 2 0.1 293 4.0 58.9 18.9, 335 <0.001

Discussion

Among our cohort of 10,231 pregnant women, we found that three-fifths presented to ANC after 16 weeks GA and one-fourth presented after 24 weeks GA, with an mean GA at presentation of 19 weeks. These rates are similar to those reported by the Rwandan Ministry of Health [16], and are consistent with patterns of delayed initiation of ANC across East Africa [1618]. While Rwanda has been successful in achieving near-universal attendance at ANC, our results demonstrate that the majority of women continue to present well beyond the country’s goal of initiating care before 16 weeks GA. In order to realize the full benefits of ANC attendance–including early identification and management of pregnancy-related risk factors–increased emphasis should be placed on promoting early initiation of care.

Rwanda has made it a national priority to improve access to ANC. In 2007 Rwanda implemented a CHW outreach program as a primary strategy to promote ANC attendance [40]. CHWs are responsible for identifying pregnant women, providing prenatal health education, and encouraging attendance at ANC. Interventions that build on the existing outreach systems to increase early access to ANC will be most effective if they are tailored towards the populations at the greatest risk of delaying care. In this investigation we identified multiple predictors of late presentation to ANC-1, suggesting a few priority groups.

We found that lower educational attainment was associated with delayed ANC-1, which is consistent with findings from studies in the region [19, 22]. This might be directly due to increased knowledge about the importance of ANC or may be due to increased autonomy and financial independence associated with higher educational attainment. While both older and younger ages have been identified as predictors of late ANC initiation in other studies, we found that younger participants were more likely to delay ANC-1 in our cohort [17, 41, 42]. Various factors may be at play, including the stigma and social isolation associated with teenage pregnancy [43]. Our results suggest that targeting adolescents and those with lower educational attainment may be particularly high-yield in improving rates of early ANC attendance and should be a priority for CHW outreach efforts.

Participants in our cohort who received a pregnancy test were less likely to delay ANC-1. Pregnancy testing has been shown to increase early attendance at ANC in multiple low-resource contexts [41, 44, 45], which may be due to earlier pregnancy discovery [18, 19, 46]. Although our analysis did not specifically assess whether patients delayed care due to late discovery, our results suggest that access to pregnancy testing may increase early attendance. Home pregnancy testing has been successfully incorporated into CHW outreach efforts in other low-resource settings, and has been linked to earlier ANC attendance [45, 47]. In Rwanda, where a robust CHW outreach program already exists but access to home pregnancy testing is limited, incorporating pregnancy testing in regular outreach efforts may be an effective strategy to increase early attendance at ANC.

We anticipated that participants who sought care within their home district would be less likely to delay ANC-1. The current ANC care system in Rwanda was restructured in the past two decades, with the goal of providing the majority of ANC services at community health centers [48]. Our results confirm that those who attended their first ANC-1 visit at their local health center were less likely to delay care. While local community health centers improve initial access to care, patients with high-risk conditions identified at ANC-1 may still be required to travel to a district hospital for ongoing ANC [48]. Patients with complex pregnancy-related risk factors, who benefit the most from consistent prenatal care, many face the greatest barriers to accessing services due to the distance of referral centers. Further research is warranted to explore the impact of referral to a district hospital on continued engagement with ANC services for women with identified complications.

Multiparous patients in our cohort were more likely to present late to care. Reasons for delaying ANC among multiparous patients is complex, although some evidence suggests that women delay ANC due to a history of uncomplicated pregnancies and the perception that their current pregnancy will be similarly uncomplicated [2426]. Given this emerging evidence, we expected that multiparous women who had experienced an obstetric complication would be less likely to delay ANC. The results of our analysis were mixed. While women who reported a preterm birth or low birthweight delivery were less likely to delay ANC, those with a history of stillbirth or neonatal mortality delayed care at rates similar to those without a history of these adverse outcomes. Preterm and low birthweight deliveries generally result in neonatal hospitalization, while a stillbirth or neonatal death may not. Past experience with the healthcare system may explain earlier attendance among patients with a history of preterm or low birthweight deliveries. Those with a history of a spontaneous abortion were also less likely to delay ANC, which may be due to increased motivation to prevent future pregnancy losses [18]. In an effort to increase attendance at ANC, educational outreach should stress that early monitoring and interventions during pregnancy may decrease adverse neonatal outcomes, including infant death.

Surprisingly, we found that women who contributed to their household’s income were more likely to delay ANC-1. Our results stand in contrast to other investigations that have found that women in paid employment positions utilize ANC at higher rates than those who are unemployed [19]. One possible explanation for our results is that mothers may prioritize the immediate financial needs of their families over early attendance at ANC in this low-resource context. Additional studies are needed to better understand the impact of maternal employment on ANC utilization in Rwanda.

Our results also demonstrated striking disparities in ANC attendance between districts. Nyamasheke had the lowest proportion of women presenting after 16 weeks at 45.1%, while Rubavu had the highest proportion at 75.3%. Similarly, only 13.5% of women in Nyamasheke presented after 24 weeks GA, while 40.6% of women in Rubavu presented after 24 weeks. In addition to their CHW program, a pillar of Rwanda’s maternal health strategy is their health center incentivization scheme, which rewards facilities based on the number of patients who attend ANC-1 before 16 weeks and complete at least 4 ANC visits [49]. These types of incentive schemes may affect how local health centers interact with communities and work to encourage women in their communities to participate in care [50]. Further investigation into the successes of high-performing districts may yield additional insights into effective strategies for encouraging women to seek early antenatal care.

This investigation also examined differences in the obstetric risk factors identified at participants’ first ANC visit. Given that the risk of developing certain obstetric risk factors increases throughout pregnancy, we expected that presenting late to care would increase the likelihood of having an obstetric complication identified at ANC-1. Our analysis confirmed these results, and we found that women presenting after 16 weeks GA were more likely to have an obstetric risk factor identified at ANC-1. While women who present early to care may go on to develop a risk factor later on in pregnancy, early and frequent access to care promotes timely identification of new obstetric risks. We also examined the effect of parity on the risk factors identified at ANC-1 and found that multiparous women presented to ANC-1 with similar risk factors to nulliparous women. In the setting of emerging evidence that multiparous women may delay ANC due to the belief that their pregnancies are lower-risk [46], these results raise concern that delays in care among multiparous patients may result in later identification of important obstetrical risk factors.

Despite conducting data strengthening activities, our investigation found lower than expected rates of obstetric risk factors in our study population. Some of the most important causes of maternal and neonatal morbidity and mortality including hypertension [5153], HIV positive status [54], and malnutrition (MUAC) [55, 56] were below expected prevalence. Other important screening results, including diabetes and syphilis, were systematically missing from the health record and thus were excluded from our final analysis. Low MUAC represents a particularly interesting example of an underreported risk factor, as maternal malnutrition is highly visible during pregnancy and should be easily identified both by community-based CHWs and ANC providers. These results demonstrate weaknesses in the identification and documentation of modifiable obstetrics risk factors, one of the most important functions of ANC.

In the context of recent calls from the WHO to double the number of ANC contacts, our results raise concerns about the quality of care within the current four visit system. One Rwandan study found that basic screening and prophylactic care was missing in up to 15% of ANC patient charts. This study also reported large gaps in provider knowledge, including the ability to identify key pregnancy-related conditions that would require urgent referral to a higher level facility [57]. While Rwanda has a stronger healthcare system than many of its regional peers, our data show there is room for improvement in terms of capturing important risk factors in the antenatal period. A few studies have demonstrated that increasing the number of ANC visits a woman attends does not necessarily result in improved pregnancy outcomes, if important screening and educational activities are missed [33, 58]. If Rwanda moves towards an eight-visit system, using additional contacts as an opportunity to enhance the delivery of educational activities and screening through provider trainings and standardized protocols will be important for improving maternal and neonatal outcomes.

Limitations

Since this investigation was a secondary data analysis and some variables had limited completion rates, we were unable to assess the impact of certain factors such as health insurance or family wealth on ANC attendance. Even though Rwanda has the highest insurance rates in sub-Saharan African (over 90%) and the majority of ANC services are provided within community health centers to decrease the financial burden of travel, financial concerns may impact ANC attendance for the small proportion of uninsured women [59, 60]. In addition, certain variables such as marital status and pregnancy intention were not collected in the primary dataset, and thus we were unable to include them in our analysis. Due to poor data quality, we were unable to assess important obstetric risk factors typically identified at ANC, including diabetes and syphilis. We were also unable include infection with malaria, as malaria testing is not required at ANC-1 and many health systems did not screen for malaria at their prenatal visits. While data strengthening exercises were conducted at each participating health center in an attempt to improve variable completeness, a parallel system of data collection would have strengthened this study and ensured a more accurate capture of clinical information.

Conclusions

Early attendance at ANC is important for the early identification and management of obstetric risk factors. In Rwanda, increasing access to ANC is one of the leading health sector priorities. While the country has been successful in achieving near universal access to at least one ANC visit, our study found that the majority of Rwandan women continue to present late to care. Through this investigation, we identified multiple sociodemographic predictors of late presentation to ANC and proposed a few possible interventions to promote earlier ANC attendance. Building upon Rwanda’s robust CHW network to administer pregnancy testing is one example and may prove to be a low-cost way to prompt earlier attendance at ANC clinics. CHW outreach has been very successful in increasing overall attendance at ANC and targeting their efforts towards those most at risk of delaying ANC is another strategy that may prompt earlier care initiation. Existing efforts by the Rwandan government to locate ANC services within communities, achieve universal health insurance, and leverage CHWs to link communities to care are important steps towards improving early ANC attendance. Our results also demonstrated gaps in the identification and documentation of important obstetric risk factors at ANC-1 visits. Health centers should focus on enhancing the delivery of educational activities and improving antenatal screening through standardized provider trainings and protocols.

Supporting information

S1 File. Participant enrollment survey.

(DOCX)

Acknowledgments

We are grateful to the PTBi-Rwanda field coordinators who supported the administration of our surveys and collection of clinical data from our health centers. We thank the PTBi-Rwanda project managers and staff, who contributed to data cleaning and organization for the greater East Africa Preterm Birth Initiative.

Data Availability

Data files are available at the following DOI: 10.17605/OSF.IO/NKABY.

Funding Statement

This work is part of the East Africa Preterm Birth Initiative which is funded by the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Carroli G, Rooney C, Villar J. How effective is antenatal care in preventing maternal mortality and serious morbidity? An overview of the evidence. Paediatric Perinatal Epidemiology. 2001Jan;15:1–42. [DOI] [PubMed] [Google Scholar]
  • 2.Doku DT, Neupane S. Survival analysis of the association between antenatal care attendance and neonatal mortality in 57 low- and middle-income countries. International Journal of Epidemiology. 2017Oct1;46(5):1668–77. doi: 10.1093/ije/dyx125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Arunda M, Emmelin A, Asamoah BO. Effectiveness of antenatal care services in reducing neonatal mortality in Kenya: analysis of national survey data. Global Health Action. 2017Jan1;10(1):1328796. doi: 10.1080/16549716.2017.1328796 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Raatikainen K, Heiskanen N, Heinonen S. Under-attending free antenatal care is associated with adverse pregnancy outcomes. BMC Public Health. 2007Sep27;7(1):268. doi: 10.1186/1471-2458-7-268 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.McCurdy RJ, Kjerulff KH, Zhu J. Prenatal care associated with reduction of neonatal mortality in Sub-Saharan Africa: evidence from Demographic and Health Surveys. Acta Obstetricia et Gynecologica Scandinavica. 2011;90(7):779–90. doi: 10.1111/j.1600-0412.2011.01133.x [DOI] [PubMed] [Google Scholar]
  • 6.Alkema L, Chou D, Hogan D, Zhang S, Moller A-B, Gemmill A, et al. Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group. The Lancet. 2016Jan30;387(10017):462–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.UN Inter-agency Group for Child Mortality Estimation. Levels & Trends in Child Mortality: Report 2015. 2015 p. 36.
  • 8.UNICEF, World Health Organization, World Bank Group, United Nations. Levels and Trends in Child Mortality: Report 2019.
  • 9.Ahmed I, Ali SM, Amenga-Etego S, Ariff S, Bahl R, Baqui AH, et al. Population-based rates, timing, and causes of maternal deaths, stillbirths, and neonatal deaths in south Asia and sub-Saharan Africa: a multi-country prospective cohort study. The Lancet Global Health. 2018Dec1;6(12):e1297–308. doi: 10.1016/S2214-109X(18)30385-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kalisa R, Rulisa S, van den Akker T, van Roosmalen J. Maternal Near Miss and quality of care in a rural Rwandan hospital. BMC Pregnancy and Childbirth. 2016Oct21;16(1):324. doi: 10.1186/s12884-016-1119-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Pervin J, Rahman SM, Rahman M, Aktar S, Rahman A. Association between antenatal care visit and preterm birth: a cohort study in rural Bangladesh. BMJ Open. 2020Jul1;10(7):e036699. doi: 10.1136/bmjopen-2019-036699 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.WHO Recommendations on Antenatal Care for a Positive Pregnancy Experience [Internet]. Geneva: World Health Organization; 2016. (WHO Guidelines Approved by the Guidelines Review Committee). http://www.ncbi.nlm.nih.gov/books/NBK409108/ [PubMed]
  • 13.Say L, Chou D, Gemmill A, Tunçalp Ö, Moller A-B, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. The Lancet Global Health. 2014Jun1;2(6):e323–33. doi: 10.1016/S2214-109X(14)70227-X [DOI] [PubMed] [Google Scholar]
  • 14.Rööst M, Altamirano VC, Liljestrand J, Essén B. Does antenatal care facilitate utilization of emergency obstetric care? A case-referent study of near-miss morbidity in Bolivia. Acta Obstetricia et Gynecologica Scandinavica. 2010Mar1;89(3):335–42. doi: 10.3109/00016340903511050 [DOI] [PubMed] [Google Scholar]
  • 15.Berhan Y, Berhan A. Antenatal Care as a Means of Increasing Birth in the Health Facility and Reducing Maternal Mortality: A Systematic Review. Ethiop J Health Sci. 2014Sep;24(0 Suppl):93–104. doi: 10.4314/ejhs.v24i0.9s [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.National Institute of Statistics of Rwanda (NISR), Rwanda Ministry of Health (MOH), I International. Rwanda Demographic and Health Survey, 2014–2015. Rockville, Maryland, USA: NISR, MOH, and ICF International; 2015. [Google Scholar]
  • 17.Ebonwu J, Mumbauer A, Uys M, Wainberg ML, Medina-Marino A. Determinants of late antenatal care presentation in rural and peri-urban communities in South Africa: A cross-sectional study. PLoS ONE. 2018;13(3):e0191903. doi: 10.1371/journal.pone.0191903 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gross K, Alba S, Glass TR, Schellenberg JA, Obrist B. Timing of antenatal care for adolescent and adult pregnant women in south-eastern Tanzania. BMC Pregnancy and Childbirth. 2012Mar21;12(1):16. doi: 10.1186/1471-2393-12-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Simkhada B, Teijlingen ER van, Porter M, Simkhada P. Factors affecting the utilization of antenatal care in developing countries: systematic review of the literature. J Adv Nurs. 2008Feb;61(3):244–60. doi: 10.1111/j.1365-2648.2007.04532.x [DOI] [PubMed] [Google Scholar]
  • 20.Adamu YM, Salihu HM. Barriers to the use of antenatal and obstetric care services in rural Kano, Nigeria. Journal of Obstetrics and Gynaecology. 2002Jan1;22(6):600–3. doi: 10.1080/0144361021000020349 [DOI] [PubMed] [Google Scholar]
  • 21.Kisuule I, Kaye DK, Najjuka F, Ssematimba SK, Arinda A, Nakitende G, et al. Timing and reasons for coming late for the first antenatal care visit by pregnant women at Mulago hospital, Kampala Uganda. BMC Pregnancy Childbirth. 2013May25;13:121. doi: 10.1186/1471-2393-13-121 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Birmeta K, Dibaba Y, Woldeyohannes D. Determinants of maternal health care utilization in Holeta town, central Ethiopia. BMC Health Services Research. 2013Jul3;13(1):256. doi: 10.1186/1472-6963-13-256 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Gebremeskel F, Dibaba Y, Admassu B. Timing of First Antenatal Care Attendance and Associated Factors among Pregnant Women in Arba Minch Town and Arba Minch District, Gamo Gofa Zone, South Ethiopia [Internet]. Journal of Environmental and Public Health. 2015 [cited 2019 Mar 6]. https://www.hindawi.com/journals/jeph/2015/971506/abs/ [DOI] [PMC free article] [PubMed]
  • 24.Påfs J, Musafili A, Binder-Finnema P, Klingberg-Allvin M, Rulisa S, Essén B. ‘They would never receive you without a husband’: Paradoxical barriers to antenatal care scale-up in Rwanda. Midwifery. 2015Dec1;31(12):1149–56. doi: 10.1016/j.midw.2015.09.010 [DOI] [PubMed] [Google Scholar]
  • 25.Myer L, Harrison A. Why do women seek antenatal care late? Perspectives from rural South Africa. Journal of Midwifery & Women’s Health. 2003Jul1;48(4):268–72. doi: 10.1016/s1526-9523(02)00421-x [DOI] [PubMed] [Google Scholar]
  • 26.McCaw-Binns A, La Grenade J, Ashley D. Under-users of antenatal care: A comparison of non-attenders and late attenders for antenatal care, with early attenders. Social Science & Medicine. 1995Apr1;40(7):1003–12. doi: 10.1016/0277-9536(94)00175-s [DOI] [PubMed] [Google Scholar]
  • 27.Turyasiima M, Tugume R, Openy A, Ahairwomugisha E, Opio R, Ntunguka M, et al. Determinants of First Antenatal Care Visit by Pregnant Women at Community Based Education, Research and Service Sites in Northern Uganda. East African Medical Journal. 2014Jan1;91(9):317–322–322. [PMC free article] [PubMed] [Google Scholar]
  • 28.Iams JD, Goldenberg RL, Mercer BM, Moawad A, Thom E, Meis PJ, et al. The Preterm Prediction Study: Recurrence risk of spontaneous preterm birth. American Journal of Obstetrics and Gynecology. 1998May1;178(5):1035–40. doi: 10.1016/s0002-9378(98)70544-7 [DOI] [PubMed] [Google Scholar]
  • 29.Beta J, Akolekar R, Ventura W, Syngelaki A, Nicolaides KH. Prediction of spontaneous preterm delivery from maternal factors, obstetric history and placental perfusion and function at 11–13 weeks. Prenatal Diagnosis. 2011;31(1):75–83. doi: 10.1002/pd.2662 [DOI] [PubMed] [Google Scholar]
  • 30.Villar J, Ba’aqeel H, Piaggio G, Lumbiganon P, Miguel Belizán J, Farnot U, et al. WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal care. Lancet. 2001May19;357(9268):1551–64. doi: 10.1016/s0140-6736(00)04722-x [DOI] [PubMed] [Google Scholar]
  • 31.Manzi A, Nyirazinyoye L, Ntaganira J, Magge H, Bigirimana E, Mukanzabikeshimana L, et al. Beyond coverage: improving the quality of antenatal care delivery through integrated mentorship and quality improvement at health centers in rural Rwanda. BMC Health Services Research. 2018Feb23;18(1):136. doi: 10.1186/s12913-018-2939-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Hodgins S, D’Agostino A. The quality–coverage gap in antenatal care: toward better measurement of effective coverage. Glob Health Sci Pract. 2014Apr8;2(2):173–81. doi: 10.9745/GHSP-D-13-00176 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Benova L, Tunçalp Ö, Moran AC, Campbell OMR. Not just a number: examining coverage and content of antenatal care in low-income and middle-income countries. BMJ Global Health. 2018Apr1;3(2):e000779. doi: 10.1136/bmjgh-2018-000779 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Carroli G, Villar J, Piaggio G, Khan-Neelofur D, Gülmezoglu M, Mugford M, et al. WHO systematic review of randomised controlled trials of routine antenatal care. The Lancet. 2001May19;357(9268):1565–70. doi: 10.1016/S0140-6736(00)04723-1 [DOI] [PubMed] [Google Scholar]
  • 35.Musange SF, Butrick E, Lundeen T, Santos N, Azman Firdaus H, Benitez A, et al. Group antenatal care versus standard antenatal care and effect on mean gestational age at birth in Rwanda: protocol for a cluster randomized controlled trial. Gates Open Res. 2019;3:1548. doi: 10.12688/gatesopenres.13053.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Hager ER, Quigg AM, Black MM, Coleman SM, Heeren T, Rose-Jacobs R, et al. Development and Validity of a 2-Item Screen to Identify Families at Risk for Food Insecurity. Pediatrics. 2010Jul1;126(1):e26–32. doi: 10.1542/peds.2009-3146 [DOI] [PubMed] [Google Scholar]
  • 37.Assaf S, Staveteig S, Birungi F. Trends in Maternal Health in Rwanda: Further Analysis of the 2014–15 Demographic and Health Survey. Rockville, Maryland, USA: ICF; 2018 Jan. Report No.: DHS Further Analysis Reports No. 108.
  • 38.Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989Jan;129(1):125–37. doi: 10.1093/oxfordjournals.aje.a115101 [DOI] [PubMed] [Google Scholar]
  • 39.Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993Dec1;138(11):923–36. doi: 10.1093/oxfordjournals.aje.a116813 [DOI] [PubMed] [Google Scholar]
  • 40.Bucagu M. Improving Maternal Health in Rwanda: The Role of Community-Based Interventions: A Systematic Review (2005–2015). J Community Med Health Educ [Internet]. 2016. [cited 2020 Dec 21];6(3). Available from: https://www.omicsonline.org/open-access/improving-maternal-health-in-rwanda-the-role-of-communitybasedinterventions-a-systematic-review-20052015-2161-0711-1000434.php?aid=73872 [Google Scholar]
  • 41.Gudayu TW, Woldeyohannes SM, Abdo AA. Timing and factors associated with first antenatal care booking among pregnant mothers in Gondar Town; North West Ethiopia. BMC Pregnancy and Childbirth. 2014Aug25;14(1):287. doi: 10.1186/1471-2393-14-287 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Manzi A, Munyaneza F, Mujawase F, Banamwana L, Sayinzoga F, Thomson DR, et al. Assessing predictors of delayed antenatal care visits in Rwanda: a secondary analysis of Rwanda demographic and health survey 2010. BMC Pregnancy and Childbirth. 2014Aug28;14(1):290. doi: 10.1186/1471-2393-14-290 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Uwizeye D, Muhayiteto R, Kantarama E, Wiehler S, Murangwa Y. Prevalence of teenage pregnancy and the associated contextual correlates in Rwanda. Heliyon. 2020Oct1;6(10):e05037. doi: 10.1016/j.heliyon.2020.e05037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Morroni C, Moodley J. The role of urine pregnancy testing in facilitating access to antenatal care and abortion services in South Africa: a cross-sectional study. BMC Pregnancy and Childbirth. 2006Aug7;6(1):26. doi: 10.1186/1471-2393-6-26 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Comfort AB, Juras RC, Bradley SEK, Ranjalahy Rasolofomanana J, Noeliarivelo Ranjalahy A, Harper CC. Do home pregnancy tests bring women to community health workers for antenatal care counselling? A randomized controlled trial in Madagascar. Health Policy Plan. 2019Oct1;34(8):566–73. doi: 10.1093/heapol/czz080 [DOI] [PubMed] [Google Scholar]
  • 46.Pell C, Meñaca A, Were F, Afrah NA, Chatio S, Manda-Taylor L, et al. Factors affecting antenatal care attendance: results from qualitative studies in Ghana, Kenya and Malawi. PLoS ONE. 2013;8(1):e53747. doi: 10.1371/journal.pone.0053747 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Andersen K, Singh A, Shrestha MK, Shah M, Pearson E, Hessini L. Early pregnancy detection by female community health volunteers in Nepal facilitated referral for appropriate reproductive health services. Global Health: Science and Practice. 2013Nov1;1(3):372–81. doi: 10.9745/GHSP-D-12-00026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Kalk A, Paul FA, Grabosch E. ‘Paying for performance’ in Rwanda: does it pay off? Tropical Medicine & International Health. 2010Feb1;15(2):182–90. doi: 10.1111/j.1365-3156.2009.02430.x [DOI] [PubMed] [Google Scholar]
  • 49.Republic of Rwanda Ministy of Health. Health Sector Policy [Internet]. 2015. http://www.moh.gov.rw/fileadmin/templates/policies/Health_Sector_Policy___19th_January_2015.pdf
  • 50.Basinga P, Gertler PJ, Binagwaho A, Soucat AL, Sturdy J, Vermeersch CM. Effect on maternal and child health services in Rwanda of payment to primary health-care providers for performance: an impact evaluation. The Lancet. 2011Apr23;377(9775):1421–8. [DOI] [PubMed] [Google Scholar]
  • 51.Semasaka JPS, Krantz G, Nzayirambaho M, Munyanshongore C, Edvardsson K, Mogren I. Self-reported pregnancy-related health problems and self-rated health status in Rwandan women postpartum: a population-based cross-sectional study. BMC Pregnancy Childbirth. 2016Dec;16(1):1–17. doi: 10.1186/s12884-016-1138-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Berhe AK, Kassa GM, Fekadu GA, Muche AA. Prevalence of hypertensive disorders of pregnancy in Ethiopia: a systemic review and meta-analysis. BMC Pregnancy and Childbirth. 2018Jan18;18(1):34. doi: 10.1186/s12884-018-1667-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Hoodbhoy D, Payne B. The FIGO Textbook of Pregnancy Hypertension. In 2016.
  • 54.Nsanzimana S, Remera E, Kanters S, Mulindabigwi A, Suthar AB, Uwizihiwe JP, et al. Household survey of HIV incidence in Rwanda: a national observational cohort study. The Lancet HIV. 2017Oct1;4(10):e457–64. doi: 10.1016/S2352-3018(17)30124-8 [DOI] [PubMed] [Google Scholar]
  • 55.Assefa N, Berhane Y, Worku A. Wealth Status, Mid Upper Arm Circumference (MUAC) and Antenatal Care (ANC) Are Determinants for Low Birth Weight in Kersa, Ethiopia. PLoS One [Internet]. 2012. Jun 29;7(6). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386987/ [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Christian P, Katz J, Wu L, Kimbrough-Pradhan E, Khatry SK, LeClerq SC, et al. Risk factors for pregnancy-related mortality: A prospective study in rural Nepal. Public Health. 2008Feb1;122(2):161–72. doi: 10.1016/j.puhe.2007.06.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Rurangirwa AA, Mogren I, Ntaganira J, Govender K, Krantz G. Quality of antenatal care services in Rwanda: assessing practices of health care providers. BMC Health Services Research. 2018Nov19;18(1):865. doi: 10.1186/s12913-018-3694-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Carvajal–Aguirre L, Amouzou A, Mehra V, Ziqi M, Zaka N, Newby H. Gap between contact and content in maternal and newborn care: An analysis of data from 20 countries in sub–Saharan Africa. J Glob Health [Internet]. 7(2). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804037/ doi: 10.7189/jogh.07.020501 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Makaka A, Breen S, Binagwaho A. Universal health coverage in Rwanda: a report of innovations to increase enrolment in community-based health insurance. The Lancet. 2012Oct21;380:S7. [Google Scholar]
  • 60.Chemouni B. The political path to universal health coverage: Power, ideas and community-based health insurance in Rwanda. World Development. 2018Jun1;106:87–98. [Google Scholar]

Decision Letter 0

Hanna Landenmark

18 Nov 2020

PONE-D-20-22930

Towards stronger antenatal care: understanding predictors of late presentation to antenatal services and implications for obstetric risk management in Rwanda

PLOS ONE

Dear Dr. Schmidt,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please see the comments from the reviewers below. The reviewers have requested further elaboration on the statistical analysis, how the methodology ties in with the aims, justification for specific choices in the methodology and analysis, as well as clarification on certain specific points.

Please submit your revised manuscript by Dec 28 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Hanna Landenmark

Associate Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. "You indicated that you had ethical approval for your study. In your Methods section, please ensure you have also stated whether you obtained consent from parents or guardians of the minors included in the study or whether the research ethics committee or IRB specifically waived the need for their consent.

3. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

4. Please ensure you have included the registration number for the clinical trial referenced in the manuscript.

5. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Partly

Reviewer #4: Yes

Reviewer #5: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Reviewer #4: No

Reviewer #5: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

Reviewer #4: Yes

Reviewer #5: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: A secondary analysis was conducted with the aim of identifying factors associated with delayed initiation of antenatal care (ANC) and comparing the risks between those presenting early and late for care. Adjusting for clusters, backwards stepwise regression analysis were used to identify predictors of first ANC visit. The statistical methods are vague; therefore, the conclusions are unclear.

Major revision:

It seems that either logistic regression models should be used when predicting the dichotomies of ≥ 16 weeks or ≥ 24 weeks or linear regression models to predict the continuous value for week of ANC-1. Additionally, in the backward selection model it is common to include candidate predictors with univariate p-values ≤ 0.10.

Minor revisions:

Line 179: Chi-square tests are used to show association. Use logistic or linear regression models for prediction, even for univariate tests.

Reviewer #2: Abstract

The results are confusing. The study set out to assess factors associated with delayed initiation of the first antenatal visit, in lines 31-33. However, it is reporting factors associated with early initiation of antenatal care in part of the results section, rather than factors associated with late initiation of antenatal care, in lines 41-47.

• Educational attainment, prior spontaneous abortion and pregnancy testing were associated with earlier ANC-1 (p<0.001).

• Women with a prior preterm (p=0.024) or low birthweight (p=0.023) delivery were more likely to present before 16 weeks GA, while history of stillbirth or neonatal death were not associated with timing of ANC-1.

• Women presenting before 16 weeks GA were more likely to have no obstetric risk factors identified at ANC-1 (p<0.001).

In lines 49-54, the authors present a discussion, but do not have a clear conclusion. Also, the authors do not indicate how awareness of the importance of antenatal care would be increased. They also do not indicate how health system strengthening may be done to identify the suggested risk factors. They do not seem to have a conclusion. They state:

• Outreach efforts should focus on increasing mothers’ awareness of the benefits of ANC and emphasize the importance of early identification and management of pregnancy-related complications.

• While fewer risk factors were identified among women presenting less than 16 weeks, lower than expected rates were identified in the study population overall.

Main article

In lines 65-71, the authors state that many of the complications that lead to adverse outcomes can be maternal or neonatal outcomes can be prevented through early antenatal care, and mention hemorrhage as one of the factors, yet antenatal care may not mitigate hemorrhage-related maternal morbidity and mortality. Similarly, they suggest that antenatal care may reduce infection-related neonatal morbidity and mortality without any suggestion of how this can be achieved. This to me seems speculative, considering that most neonatal infection follow peripartum or postnatal complications.

In lines 84-93, the authors should provide an explanation of how many of the suggested factors lead to late presentation of antenatal care.

Methods

In lines 158-162, the authors need to indicate the definitions used for anemia, hypertension, proteinuria and diabetes, as well as how these variables were measured. Is it present/absent or a definite cut off?

In lines 171-178, the data analysis conducted is not clear. At analysis, the authors state:

Variables that were significantly associated with delayed presentation to ANC at the 172

�=0.05 level were retained for multivariable model building. This is too strict and erroneous, as

they should have included all variables with a p-value of less than 0.2 or even those with clinical

significance, such as complications in a prior pregnancy. The backward and stepwise method of

variable selection is also not clear.

Discussion

The discussion does not provide an explanation of how the suggested factors operate, for example educational attainement, parity, prior complications etc.

It is also not clear how parity as a moderator was assesed, when you view the results presented, as the stratified analysies compared primiparous and multiparous, rather than parity as an independent variable.

In lines 331-335, the authors state that : This investigation also examined differences in the obstetric risk factors identified at participants’ first ANC visit. Women presenting before 16 weeks GA were more likely to have no identified risk factors (“none”). This may be partially due to the fact that some obstetric risk factors, such as multiple births or hypertension, may be identified at a higher rate at later gestational ages. However, the focus of their stated objective was to assess factors associated with late antenatal attendance. Also, their explanation of of lack of identifiable risk factor is not clear to me.

The authors add, in lines 338-340, that: multiparous patients do not appear to be at lower

risk of pregnancy-related complications. Multiparous women should be encouraged to continue

to attend ANC, due to the risk of delayed identification of modifiable risk factors. This also is not clear to me.

The authors should comment, in the discussion, on the quality of antenatal care, that is activities conducted per visit, rather than the number and timing of antenatal care visits, and the influence of this on pregnancy outcomes (maternal and mneonatal outcomes).

Reviewer #3: 1. Abstract

� On line 41‘’Earning income’’: not clear

� Line 48, use conclusion instead of discussion

2. Introduction

� On page 6 line 112 ‘‘this analysis identified predictors of late (≥16 weeks GA)…’’. Why did you use 16 weeks of gestational age as a cut-off pint? WHO recommends pregnant women have to start their first ANC booking within the first 12 weeks of gestational age. See the following references.

� World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience [Internet]. Geneva, Switzerland; 2016. Available from: ttps://apps.who.int/iris/bitstream/10665/250796/.../9789241549912-eng.pdf

� Tuncalp Ӧ, Pena-Rosas J, Lawrie T, Bucagu M, Oladapo O, Portela A, et al. WHO recommendations on antenatal care for a positive pregnancy experience — going beyond survival. BJOG. 2017;124:860–2.

3. Methods

� From line 132-133, ‘‘only participants with completed ANC care records were included in the final analysis.’’ If this is the case, is it representative?

4. Analysis

� Data analysis is not well addressed and robust

� From line 165-166, ‘‘Chi-squared tests were performed to identify variables

significantly associated with late presentation to ANC.’’ why you preferred Chi-squared tests than odds ratios?

� Not clear on the selection of measures of association used. For instance, Chi-squared tests vs. Odds ratios.

5. Ethical consideration

� Line 198, ‘‘Written consent was obtained from all participants.’’ How did you secure it? Are all read and write to give you written consent?

6. Discussion

� Lacks author argument

7. Limitations

� Line 370, ‘‘we found that many clinical variables had poor quality.’’ many clinical variables specifically………had poor quality

Reviewer #4: Towards stronger antenatal care: understanding predictors of late

presentation to antenatal services and implications for obstetric risk

management in Rwanda

This study is of Public health relevance. The authors identified factors associated with delayed initiation of ANC and describe differences in the obstetric risks identified at the first ANC (ANC-1) visit between women presenting early and late to care.

I have the following comments

1. L36 & L172…authors claimed to have used “Cluster-robust standard error models”. This is a model estimation method and not a model in itself. In essence, you used logistic regression and controlled for the clustering effect of the health centres

2. What was the level of significance adopted?

3. What was the main study outcome and variables explored?

4. L127 …what were the controls

5. What is the rationale for grouping women aged 20 to 34 together? This is a critical age group where most pregnancy occurred. The behaviour of young adults (20-24 years) are very distinct from those aged 25-34 years. Authors should reanalyse

6. Important variables such as Type of marriage (monogamy/ polygamy) was, autonomy, decision making power by the women were excluded

7. Table 3: Why present both coefficient estimates and odds ratio? Delete the two columns on “Estimate (SE)”. It is redundant.

8. Did you adjust for multicollinearity among the explanatory variables?

9. Did authors assess the relationship between individual explanatory variables before choosing them as candidate variables in the multiple regression model?

10. It is usual to first do this assessment (bivariate regression) and include only the variables that were significant at a specified level (say 10 or 20%) before you run the multiple regression. The outputs of the bivariate regression are the odds ratio, sometimes called crude odds ratio (COR) while those from the multiple regression are called adjusted odds ratio (AOR)

11. Tables 4 and 5 should precede Table 3

12. Why were the risk factors in Tables 4 and 5 excluded from the regression model in Table 3? Were they insignificant?

13. There are typos and grammar issues

14. Authors should make the public health importance of this study clearer

Reviewer #5: Reviewer's report:

Initiating antenatal care (ANC) in the first trimester and identifying obstetric risk factors early are crucial for improving birth outcomes. Also, service providers’ knowledge of predictors of initiation of ANC has implications for obstetric risk management. This can help improve quality of care. However, English language needs some input; a few have provided.

General comments

1. The abstract convey what is in the manuscript

2. The data is sound.

3. The method section of the manuscript requires a major revision

4. The tables are genuine and well described

5. Some parts of the discussions needs revision to situate especially contrasting results in academic discourse

6. Conclusions reflect the results

I thus, recommend that the manuscript be accepted and the authors asked to revise the manuscript before publication.

Abstract

Word count =306

1. The title: Towards stronger antenatal care: understanding predictors of late presentation to antenatal services and implications for obstetric risk management in Rwanda

The title needs revision to cover early initiation of ANC (<16 weeks) since it is part of the analysis as shown in Table 1 and the conclusion

Introduction

1. P. 5, line 89: insert ‘as’ for the sentence read such as the practice of disclosing pregnancy after the second trimester.

2. P. 5, line 90-91: I suggest ‘poor experiences’ be replaced with ‘negative experiences’

3. P. 7, line 119-121: The authors should avoid repeating words sentences. The second ‘how’ in the sentence. I suggest: …, and inform messages tailored to multiparious and nulliparous women.

4. P. 7, 133: … completed ANC care… the ‘care’ is repetition and should be deleted.

Results

5. P. 10, line 203 and 206-208: By conversion, a sentence should not begin with a figure. I suggest the sentences should be re-written.

6. P. 15 and 16, Tables 1, 2, 3 and 4 and 5: The ‘p-values’. The ‘p’ should be capitalised as ‘P-values’

7. P. 16: Idetified is not necessary in Table 5

8. All the information in brackets in Tables 1, 2, 3 and 4 (≥ 16 weeks GA) and very late (≥ 24 weeks GA) is not necessary. They are already difined in the text.

9. I expect the authors to emphasise finding regarding the benefits of initiating ANC < 16 weeks.

Discussion

10. P. 17, line 276: Despite ongoing to increase early ANC attendance, that the .... ‘that’ should be deleted.

11. P. 17, 283-287: I suggest the authors look for evidence to explain and support their assertion that contribution to household income was a stronger predictor of delayed ANC-1. Also, could you please emphasise what your study adds?

12. P. 18, line 295: More effective strategy increase .... There should be ‘to’ as: ... strategy to increase ...

13. P. 18, line 300-302: However, barriers to continuing ANC care may emerge for women for whom ANC-1. The sentence should be: However, barriers to continuing ANC care may emerge for women for whom ANC-1. I suggest ‘ANC’ be deleted and ‘for whom’ replaced with ‘whose’

14. P. 19, line 333: why put ‘none’ into brackets. The sentence clear without ‘none’

15. P. 20, line 342: Despite conducting data strengthening activities, our investigation found lower than expected rates of obstetric risk factors were identified in the study population overall. ‘were identified’ is a repetition so need to be deleted.

16. P. 20, line 345-346: The sentence needs to be re-written to make comprehension easy for readers. I suggest: Other important screening results including diabetes and syphilis were systematically missing from the health record and thus were excluded from our final analysis.

17. P. 20, line 351: ... function of ANC care. ‘care’ is repetition and should be deleted.

18. P. 20, line 357: Delete the second ‘in’ in the sentence. i.e. This study also reported large gaps in provider knowledge, including the ability to …

Conclusion

19. The conclusion should also emphasise the benefits and predictors of early ANC attendance to inform interventions.

20. The conclusion early intervention is too unspecific as this vary in different cultures

21. The recommendation that community-based pregnancy testing could increase early pregnancy discovery and prompt earlier attendance at ANC clinics can be contested as the data does not show that late attendance is attributed to not being aware

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Daniel Kabonge Kaye

Reviewer #3: Yes: Tufa Kolola Huluka

Reviewer #4: No

Reviewer #5: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Plos.docx

Attachment

Submitted filename: Comments to Authors Reviewer 5.docx

PLoS One. 2021 Aug 25;16(8):e0256415. doi: 10.1371/journal.pone.0256415.r002

Author response to Decision Letter 0


28 Dec 2020

Please see our "Response to reviewers" letter, in which we respond to the feedback that we received from our reviewers. We appreciate the opportunity to revise and resubmit this manuscript.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Adeniyi Francis Fagbamigbe

31 Mar 2021

PONE-D-20-22930R1

Towards stronger antenatal care: Understanding predictors of late presentation to antenatal services and implications for obstetric risk management in Rwanda

PLOS ONE

Dear Dr. Schmidt,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 15 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Adeniyi Francis Fagbamigbe, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #3: (No Response)

Reviewer #5: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #3: Yes

Reviewer #5: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #3: Yes

Reviewer #5: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #5: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #5: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Major Revision:

Tables 1 and 3: In the logistic model each characteristic will have only one p-value associated with it. In other words, p-values for each level of a characteristic should not be provided. Consider consulting a qualified statistician for assistance with reporting the results from logistic regression modeling.

Minor Revisions:

1- Express p-values more precisely than “p <0.05” and "p<0.01".

2- Line 228: Clarify the meaning of alpha=0.05.

3- The standard statistical term for average is mean.

4- Line 246: Provide a measure of dispersion for the mean of GA at presentation.

5- Clarify if the results presented in Tables 4 and 5 are based on univariate or multivariate models.

6- Spell out a number when it occurs at the beginning of a sentence.

Note: Line numbers refer to those in the tracked changes version of revision 1.

Reviewer #3: I appreciate the authors' effort because I have observed a significant improvement they made into this paper at this stage. The authors have also addressed the majority of my concern during their revision. But, still, I am not convinced in some cases.

1.For instance, regarding cutoff for “late” presentation, you referenced the cutoff used by the Rwandan Ministry of Health which is not standard or consistent with the cutoff used elsewhere. When I see published articles on this issue, the majority of articles published since 2018 used >12 weeks GA as “late” presentation. My concern here is that how yours compared with results obtained by this cutoff (>12 weeks GA)? In Rwanda, it may be OK.

2.Regarding the selection of measures of association, I am not clear with the reason why did you prefer reporting p-value than odds ratio? As you know p-value conveys a little information regarding the strength and direction of association compared with odds ratio. Additionally, even your p-value report is not consistent throughout. For instance, p<0.05, p<0.001, p=0.02, p=0.03,etc. When you report the p-value, report its exact value.

Reviewer #5: The manuscript is much improved, the text flows much better and almost all the issues raised have been addressed and acceptable for publiction.

However, there are a few spelling and grammar mistakes (eg missing words, incorrect verb conjugation, missing articles etc) Examples

P.3 line 42, by conversion a sentence should not begin with a figure

P.5 line 83, ‘greater’ not necessary in the sentence.

P.6 line 101, "of" is missing in …parity and history of uncomplicated …

P23 line 437 the sentence should start with ‘The’ and replace the second ‘CHW’ with ‘their’ to avoid repetition.

P23 line 441 replace ‘demonstrated’ with ‘demonstrate’

P.22 line 402-404

This sentence seem to belittle the WHO’s call for more ANC visits. The eight ANC visit required is expected to ensure that all the necessary education activities and screening is carried out more thoroughly. Though arguably the intention is to ensure that even if a pregnant woman misses some ANC appointments, at least she will benefit from the education activities and screening than having four with some deciding to go only once or twice.

P.23 line 442-445.

You did not assess quality of care at ANC clinics. Why let your concluding statement be on quality of care. As stated above I suggest that being the last sentence, it should rather echo WHOs’ call for increasing number of ANC visits and the CHW outreach programme used to vigorously sensitise pregnant women and communities on the need to initiate ANC in the first trimester. This is likely to increase the number of ANC visits and improve pregnancy and birth outcomes as shown by your results.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #3: Yes: Tufa Kolola

Reviewer #5: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Comment.docx

PLoS One. 2021 Aug 25;16(8):e0256415. doi: 10.1371/journal.pone.0256415.r004

Author response to Decision Letter 1


15 May 2021

Please see the end of our "Response to reviewers" letter, in which we respond to the reviewer and editor comments in detail.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 2

Adeniyi Francis Fagbamigbe

2 Jun 2021

PONE-D-20-22930R2

Towards stronger antenatal care: Understanding predictors of late presentation to antenatal services and implications for obstetric risk management in Rwanda

PLOS ONE

Dear Dr. Schmidt,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 17 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Adeniyi Francis Fagbamigbe, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

I recommend minor revisions. The Reviewer 1 has raised important statistical issue amongst others. This particular issue has been raised previously but was not attended to

Table 3: Provide the overall p-values for each factor and remove the p-values associated with each level.

In logistic regression and any other regression involving categorical variables, the variable can not have a p-value, rather, all its categories except the reference category should have p-values.

You have to specify the reference category for each variable, the odds ratio for the reference categories is always 1.oo and it wont have a p-value. For example in the Age variable, if 15-19 is the reference, then age wont have p-value, 15to 19 wont have pp-value but other categories must have p-values.

Kindly note that the editorial may have no other choice to reject the manuscript if you fail to correct this in this round

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1- Line 218: Clarify alpha=0.05. When factors are tested in models, p-values rather than alpha levels are generated.

2- Table 1: The results of the logistic regression models are not summarized in a sensible fashion. Based on the authors' explanation, I determined that the OR for age of 1.01 is associated with a one-year increment in age. Typically a 5 or 10 year increment in age is commonly provided when age is modeled continuously. Additionally, if the authors prefer to model age as a categorical factor, then the reference age group must be identified so the ORs have meaning. The reference group is the group to which all other groups are compared and is typically designated as the lowest or highest category. This table requires revisions, and I suggest using categorical representations of the factors and removing the continuous representation. My suggestion of providing an overall p-value and removing the level p-values still stands because a reader can determine which groups differ by carefully examining the 95% CI for the OR. If the CI does not contain 1, it differs significantly from the reference group.

3- Table 3: Provide the overall p-values for each factor and remove the p-values associated with each level.

Reviewer #3: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #3: Yes: Tufa Kolola

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Aug 25;16(8):e0256415. doi: 10.1371/journal.pone.0256415.r006

Author response to Decision Letter 2


17 Jul 2021

July 15th, 2021

Dr. Adeniyi Francis Fagbamigbe

Academic Editor, PLOS ONE

Dear Dr. Fagbamigbe,

Thank you for the opportunity to continue to revise and resubmit our manuscript PONE-D-20-22930-R3, entitled “Towards stronger antenatal care: Understanding predictors of late presentation to antenatal services and implications for obstetric risk management in Rwanda.”

We appreciate the reviewer’s feedback and have responded to each of the suggestions raised during this round of reviews. We have attempted to address each point, taking in to account the feedback from our reviewer and from you, our Editor. We are invested in publishing this work with PLOS ONE, and are more than happy to make any additional changes, as necessary.

In this document we have included a response to each comment the reviewers made. In our response to reviewers, the reviewers’ comments are numbered, and our responses follow below prefaced by “Author response.” Corresponding changes are highlighted in the manuscript text in the revised file.

Thank you again for your continued consideration of our manuscript. We look forward to hearing from you in due time regarding our submission and to respond to any further questions and comments you may have.

Sincerely,

Christina Schmidt (corresponding author)

Doctor of Medicine Candidate, School of Medicine

University of California San Francisco

Email: christina.schmidt@ucsf.edu

Phone: +1 503 703 4953

Response to Editor’s comments:

I recommend minor revisions. The Reviewer 1 has raised important statistical issue amongst others. This particular issue has been raised previously but was not attended to

E1.1: Table 3: Provide the overall p-values for each factor and remove the p-values associated with each level.

In logistic regression and any other regression involving categorical variables, the variable can not have a p-value, rather, all its categories except the reference category should have p-values.

You have to specify the reference category for each variable, the odds ratio for the reference categories is always 1.oo and it wont have a p-value. For example in the Age variable, if 15-19 is the reference, then age wont have p-value, 15to 19 wont have pp-value but other categories must have p-values. Kindly note that the editorial may have no other choice to reject the manuscript if you fail to correct this in this round

Author response: Thank you for this feedback. As you have suggested, in this current revision we do not include a p-value for our reference categories. We previously designated our reference categories with the word “reference” and have adjusted them to instead read OR = 1.00 (ref). For example, for age, we selected 25-29 years as our reference category (as this is the most common age of pregnancy among our study population), and thus have listed OR = 1.00 for this group. We include a p-value and CI for each of the levels that are not the reference group (i.e. age 15-19, 20-24, 30-24 and 35+). We do not include a p-value for the overall variable (i.e. age), as you suggested in your example above. Please let us know if we have misunderstood this feedback, and if you would like us to make any additional adjustments to this table.

For Table 1, we have adjusted our table according to the feedback we received from Reviewer 1, including a p-values for the overall variable, and ORs with 95% CI for each level without p-values (see R1.2). We defer to our editorial/reviewer team and are more than happy to adjust these tables to present this data in a different way.

Thank you for your ongoing feedback on this manuscript. We have attempted to address the final comments from our reviewers and are happy to make any additional adjustments, as necessary.

Response to reviewer #1:

R1.1: Line 218: Clarify alpha=0.05. When factors are tested in models, p-values rather than alpha levels are generated.

Author response: Thank you for this feedback. We have removed this in our revised draft.

R1.2: Table 1: The results of the logistic regression models are not summarized in a sensible fashion. Based on the authors' explanation, I determined that the OR for age of 1.01 is associated with a one-year increment in age. Typically a 5 or 10 year increment in age is commonly provided when age is modeled continuously. Additionally, if the authors prefer to model age as a categorical factor, then the reference age group must be identified so the ORs have meaning. The reference group is the group to which all other groups are compared and is typically designated as the lowest or highest category. This table requires revisions, and I suggest using categorical representations of the factors and removing the continuous representation. My suggestion of providing an overall p-value and removing the level p-values still stands because a reader can determine which groups differ by carefully examining the 95% CI for the OR. If the CI does not contain 1, it differs significantly from the reference group.

Author response: We appreciate this clarification. We have adjusted our reporting and updated Table 1 accordingly, removing the p-values for each level while maintaining the 95% CIs, and providing an overall p-value. We have identified our reference levels in our updated table to facilitate interpretation of our odds ratios, indicated with OR = 1.0 (ref) in the corresponding row, and a line in the variable header itself. Of note, we selected age 25-29 as our reference level, as this is the most common age of pregnancy among our population. We appreciate your ongoing input on this work and are happy to make any additional adjustments to this table if we have misinterpreted this feedback.

R1.3: Table 3: Provide the overall p-values for each factor and remove the p-values associated with each level.

Author response: Thank you for this feedback. Please see our response to the Editor’s comments (E1.1) where we discuss adjustments to Table 3. We are more than happy to make additional changes, as necessary.

Decision Letter 3

Adeniyi Francis Fagbamigbe

9 Aug 2021

Towards stronger antenatal care: Understanding predictors of late presentation to antenatal services and implications for obstetric risk management in Rwanda

PONE-D-20-22930R3

Dear Dr. Schmidt,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Adeniyi Francis Fagbamigbe, Ph.D

Guest Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Adeniyi Francis Fagbamigbe

16 Aug 2021

PONE-D-20-22930R3

Towards stronger antenatal care: Understanding predictors of late presentation to antenatal services and implications for obstetric risk management in Rwanda

Dear Dr. Schmidt:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Adeniyi Francis Fagbamigbe

Guest Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Participant enrollment survey.

    (DOCX)

    Attachment

    Submitted filename: Plos.docx

    Attachment

    Submitted filename: Comments to Authors Reviewer 5.docx

    Attachment

    Submitted filename: Response to reviewers.docx

    Attachment

    Submitted filename: Comment.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    Data files are available at the following DOI: 10.17605/OSF.IO/NKABY.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES